FIGS (NYSE:FIGS) CFO Sells $338,145.01 in Stock

FIGS, Inc. (NYSE:FIGS) CFO Sarah Oughtred sold 23,597 shares of the business’s stock in a transaction on Monday, May 4th. The stock was sold at an average price of $14.33, for a total value of $338,145.01. Following the completion of the transaction, the chief financial officer directly owned 1,129,791 shares in the company, valued at approximately $16,189,905.03. This represents a 2.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Sarah Oughtred also recently made the following trade(s):

• On Thursday, April 2nd, Sarah Oughtred sold 10,872 shares of FIGS stock. The stock was sold at an average price of $14.44, for a total value of $156,991.68.
• On Thursday, February 5th, Sarah Oughtred sold 22,690 shares of FIGS stock. The stock was sold at an average price of $10.56, for a total value of $239,606.40.

FIGS Trading Down 24.1%

FIGS stock opened at $11.67 on Friday. The stock’s fifty day simple moving average is $15.08 and its two-hundred day simple moving average is $12.10. FIGS, Inc. has a 1-year low of $4.25 and a 1-year high of $17.48. The stock has a market cap of $1.94 billion, a P/E ratio of 53.04 and a beta of 1.12.

FIGS (NYSE:FIGS) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.02. FIGS had a return on equity of 9.77% and a net margin of 6.10%.The business had revenue of $159.90 million for the quarter, compared to analysts’ expectations of $153.15 million. The company’s quarterly revenue was up 28.0% on a year-over-year basis. As a group, analysts forecast that FIGS, Inc. will post 0.24 earnings per share for the current fiscal year.

Key Headlines Impacting FIGS

Here are the key news stories impacting FIGS this week:

• Positive Sentiment: FIGS reported first-quarter EPS of $0.03, beating the $0.01 consensus, while revenue of $159.9 million also topped estimates and rose 28% year over year. FIGS Releases First Quarter 2026 Financial Results
• Positive Sentiment: Management raised FY2026 revenue guidance to $719.5 million-$732.1 million, above Wall Street’s estimate, signaling continued growth momentum. FIGS Releases First Quarter 2026 Financial Results
• Neutral Sentiment: FIGS also announced a long-term partnership with Noah Wyle to advocate for the healthcare workforce and address medical debt, which supports brand visibility but is unlikely to move the stock on its own. FIGS and Noah Wyle Launch Long-Term Partnership…
• Negative Sentiment: Chairman Heather Hasson and CFO Sarah Oughtred both sold shares in pre-arranged 10b5-1 transactions, which can add to investor caution around insider confidence. Heather Hasson Sells 32,385 Shares of FIGS Stock
• Negative Sentiment: Despite the earnings beat, the market has reacted negatively, suggesting investors may be worried the stock had already priced in strong results or are waiting for more proof that growth can sustain. Figs delivers impressive Q1 CY2026 but stock drops 15%

Wall Street Analysts Forecast Growth

FIGS has been the topic of a number of recent research reports. Weiss Ratings raised FIGS from a “hold (c)” rating to a “hold (c+)” rating in a research report on Wednesday, April 29th. The Goldman Sachs Group raised FIGS from a “strong sell” rating to a “hold” rating in a research report on Friday, February 27th. Wall Street Zen raised FIGS from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 28th. Morgan Stanley upped their price target on FIGS from $8.00 to $15.00 and gave the company an “equal weight” rating in a research report on Monday, April 13th. Finally, BTIG Research reaffirmed a “buy” rating and set a $20.00 price target on shares of FIGS in a research report on Friday, April 24th. Two equities research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, FIGS has an average rating of “Moderate Buy” and an average price target of $15.93.

Hedge Funds Weigh In On FIGS

A number of institutional investors have recently added to or reduced their stakes in FIGS. Y Intercept Hong Kong Ltd increased its position in shares of FIGS by 943.4% during the 3rd quarter. Y Intercept Hong Kong Ltd now owns 261,232 shares of the company’s stock valued at $1,748,000 after purchasing an additional 236,195 shares during the last quarter. Vanguard Group Inc. increased its position in shares of FIGS by 4.6% during the 3rd quarter. Vanguard Group Inc. now owns 9,609,320 shares of the company’s stock valued at $64,286,000 after purchasing an additional 425,189 shares during the last quarter. Western Standard LLC bought a new position in shares of FIGS during the 3rd quarter valued at about $1,863,000. Jennison Associates LLC bought a new position in shares of FIGS during the 4th quarter valued at about $5,717,000. Finally, ProShare Advisors LLC increased its position in shares of FIGS by 24.7% during the 3rd quarter. ProShare Advisors LLC now owns 963,560 shares of the company’s stock valued at $6,446,000 after purchasing an additional 190,592 shares during the last quarter. 92.21% of the stock is currently owned by institutional investors.

FIGS Company Profile

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.